Platform Technology
Therapy where it’s needed
NeuroparticleTM Platform for Image-Guided Non-Invasive Brain Delivery of Magnetic Particles.
The Neuroparticle team has developed the NeuroparticleTM platform based on expertise in MRI imaging, materials science and drug development. The NeuroparticleTM platform enables a wide range of product applications to provide medicine directly to diseased tissues that are not accessible with conventional therapeutic approaches. Neuroparticle is initially applying this proprietary platform to create therapies that directly target ear, nose and throat (ENT) diseases. Company’s long-term goal is to use its technology to serve as a non-invasive alternative to brain cancer and other brain diseases that are primarily limited by the invasiveness of the procedure.
The NeuroparticleTM platform is comprised of two technological components
MRI
Ultra fast
High resolution
Head size
Portable
Image anatomy and particle
Activate and manipulation particle
Real time manipulation
Targeted Delivery of Particles
Low Cost
Low Field
No Cooling
No Shielding
Non-invasively pushes particles into and through brain
Particle
Single-use shape-engineered mission specific microscopic magnetic devices
Highly-uniform microscopic particles
Pre-programmed biodegradability
Can be focally concentrated
Drill through tissue without damage
Can deliver drug or gene payloads
Bypasses blood-brain barrier
Can elute drug products
Can thermally ablate solid tumors
Can concentrate drug, cell, or gene products to a specific targeted location
Enables tunable drug elution for long-term dosing
Has features that enable quick rotation to break biofilm, drill through tissue
Particle-drug complex can be customized for many diseases
Proprietary Technology Platform
NeuroparticleTM has a robust global portfolio of intellectual property. These patents cover all aspects of the MRI and particle including:
- Comfortable high magnetic gradients
- MRI Particle focus
- Particle drilling
- Real-time imaging guidance
- Particle and system manufacturing methods
- Liquid crystal particles
- Electro-permanent low-power MRI
- Denoising
All intellectual property protecting the NeuroparticleTM platform has been developed and is owned by the company.